CEO Nadav Kidron spoke to SABC News’ First Take about the potential of oral insulin.

SABC writes: “There is good news beckoning on the horizon. Oramed Pharmaceuticals a biotechnology company based in the United States and Israel is developing an oral drug delivery system aptly named Oramed’s oral insulin. This could be the first oral insulin available on the market and a game changer in how diabetes is treated.”

Listen to the full interview here.